Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2

As SARS-CoV-2 variants of concern (VOC) reduce the effectiveness of existing anti-COVID therapeutics, it is increasingly critical to identify highly potent neutralizing antibodies (nAbs) that bind to conserved regions across multiple variants, especially beta, delta, and omicron variants. Using sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Xu, Hua, Liang, Zi-teng, Zhao, Tian-ning, Zhang, Xin, Peng, Tian-bo, Wang, You-chun, Su, Xiao-dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747686/
https://www.ncbi.nlm.nih.gov/pubmed/36528147
http://dx.doi.org/10.1016/j.ijbiomac.2022.12.120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747686/
https://www.ncbi.nlm.nih.gov/pubmed/36528147
http://dx.doi.org/10.1016/j.ijbiomac.2022.12.120

Ejemplares similares